Related Experiment Videos

Role of macrophage cytokines in influenza A virus infections

T Peschke1, A Bender, M Nain

  • 1Institute of Immunology, Philipps University, Marburg, Germany.

Immunobiology
|November 1, 1993
PubMed

Insights

Influenza A virus infects monocytes and macrophages, causing cell death and a specific cytokine release pattern. Bacterial products like LPS can amplify this response, potentially leading to adverse effects.

Area of Science:

  • Immunology
  • Virology
  • Cell Biology

Background:

  • Human monocytes and murine macrophages are susceptible to Influenza A virus infection.
  • Infection leads to cell death with significant intracellular vacuolization.
  • Influenza A virus infection triggers a distinct cytokine release profile.

Purpose of the Study:

  • To investigate the effects of Influenza A virus infection on mononuclear phagocytes.
  • To characterize the cytokine response following viral infection.
  • To explore the potentiation of cytokine release by bacterial products.

Main Methods:

  • Infection of human monocytes and murine macrophages with Influenza A virus.
  • Analysis of cytokine production (IL-1 beta, IL-6, TNF-alpha, IFN-alpha/beta).
  • Assessment of cytokine mRNA accumulation and protein translation.
  • Evaluation of lipopolysaccharide (LPS) potentiation of cytokine release.

Main Results:

  • Influenza A virus infection caused low replication but significant cell death and vacuolization.
  • Infectious virus induced IL-1 beta, IL-6, and TNF-alpha; UV-inactivated virus induced IFN-alpha/beta.
  • Viral infection led to cytokine mRNA accumulation but limited protein translation.
  • Low concentrations of LPS strongly potentiated cytokine release from infected cells.

Conclusions:

  • Influenza A virus primes mononuclear phagocytes by accumulating cytokine mRNA.
  • Subsequent exposure to triggers like LPS facilitates cytokine protein translation.
  • The virus acts as a macrophage activating factor, with potential benefits in antiviral response and risks of adverse effects when amplified by bacterial products.

Related Concept Videos